Snowden Capital Advisors’s Anterix ATEX Stock Holding History

Snowden Capital Advisors’s Portfolio ATEX Stock Details ATEX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-100	Closed	-$5K	–	1097
2021 Q4	$5K	Buy	+100	New	+$6.07K	﹤0.01%	1681

Other funds holding ATEX

OCAM

Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HCL

Heard Capital LLC Chicago, Illinois $2.34B AUM 46.76% 1-Year Est. Return

BCC

Bain Capital Credit Boston, Massachusetts $368M AUM 9.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Stonehill Capital Management New York $350M AUM 73.6% 1-Year Est. Return

MFP

Michael F. Price $846M AUM 0.07% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Snowden Capital Advisors's ATEX Position: Q1 2022 in Review

Snowden Capital Advisors sold out of Anterix (ATEX) in Q1 2022, closing a stake of 100 shares — an estimated $5K sold.

Snowden Capital Advisors first reported a position in ATEX in Q4 2021 and held it in 1 quarter. The position peaked at $5K in Q4 2021. 109 funds tracked by Wall St. Rank hold ATEX as of Q1 2022.

Snowden Capital Advisors reported no remaining Anterix position as of Q1 2022 after selling out during the quarter.
Snowden Capital Advisors sold 100 Anterix shares in Q1 2022, an estimated $5K.
Snowden Capital Advisors first reported a position in Anterix in Q4 2021 and held it in 1 quarter.
Snowden Capital Advisors's Anterix position peaked at $5K in Q4 2021.
109 funds tracked by Wall St. Rank held Anterix as of Q1 2022.

Based on Snowden Capital Advisors's 13F filing for Q1 2022, filed 16 May 2022.